Linezolid for drug-resistant tuberculosis

Bhagteshwar Singh; Derek Cocker; Hannah Ryan; Derek J. Sloan

doi:10.1002/14651858.cd012836

Linezolid for drug-resistant tuberculosis

Bhagteshwar Singh
, Derek Cocker
, Hannah Ryan
, Derek J. Sloan

Research output: Contribution to journal › Article › peer-review

78 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy of linezolid when used as part of a second-line regimen for treating people with multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) pulmonary tuberculosis (TB), and to assess the prevalence and severity of adverse events associated with linezolid use in this patient group

Original language	English
Article number	CD012836
Journal	Cochrane Database of Systematic Reviews
Volume	2017
Issue number	11
DOIs	https://doi.org/10.1002/14651858.cd012836
Publication status	Published - 10 Nov 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.cd012836Licence: CC BY

Cochrane Library Singh et al-2017Final published version, 145 KBLicence: CC BY

Cite this

@article{526f8c4e56514367874fa089ed2db57e,

title = "Linezolid for drug-resistant tuberculosis",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy of linezolid when used as part of a second-line regimen for treating people with multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) pulmonary tuberculosis (TB), and to assess the prevalence and severity of adverse events associated with linezolid use in this patient group",

author = "Bhagteshwar Singh and Derek Cocker and Hannah Ryan and Sloan, \{Derek J.\}",

year = "2017",

month = nov,

day = "10",

doi = "10.1002/14651858.cd012836",

language = "English",

volume = "2017",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "11",

}

TY - JOUR

T1 - Linezolid for drug-resistant tuberculosis

AU - Singh, Bhagteshwar

AU - Cocker, Derek

AU - Ryan, Hannah

AU - Sloan, Derek J.

PY - 2017/11/10

Y1 - 2017/11/10

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy of linezolid when used as part of a second-line regimen for treating people with multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) pulmonary tuberculosis (TB), and to assess the prevalence and severity of adverse events associated with linezolid use in this patient group

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy of linezolid when used as part of a second-line regimen for treating people with multidrug-resistant (MDR-) and extensively drug-resistant (XDR-) pulmonary tuberculosis (TB), and to assess the prevalence and severity of adverse events associated with linezolid use in this patient group

U2 - 10.1002/14651858.cd012836

DO - 10.1002/14651858.cd012836

M3 - Article

SN - 1465-1858

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD012836

ER -

Linezolid for drug-resistant tuberculosis

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this